The Symposium on Personalised Medicine for Global Health takes place in Harare, Zimbabwe
The Symposium on Personalised Medicine for Global Health takes place in Harare, Zimbabwe from the 19th to the 22th of August 2019. The meeting brings together over 50 participants from four countries.
The Symposium will focus on pharmacokinetics (PK) and pharmacogenomics (PGx) based practice of individualised or precision medicine for global health. This important event underscores the German (GHPP CPA) and African (African Institute for Biomedical Science and Technology, AiBST) research collaboration within CPA (Combating Resistance in the treatment of infectious diseases by Promoting Judicious/Rational Use of Anti-infective Drugs), towards the improved use of medicines in Africa. Other key players in the meeting include, for instance, the European and Developing Countries Clinical Trial Partnerships (EDCTP) and the H3ABionet.
CPA facilitates collaborative research on optimal use of anti-infective drugs as a means to combat antimicrobial resistance. It focuses on scientific training in the field of judicious use of anti-infective drugs, therapeutic drug monitoring (TDM), pharmacogenetics and clinical pharmacology. The overall goal of this project is to launch and nurture collaborative research and thereby initiate and establish a network for the coordinated optimization of anti-infective drug use.